4.3 Article

MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis

期刊

ONCOTARGET
卷 6, 期 26, 页码 22410-22423

出版社

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.4198

关键词

colorectal cancer; hepatic sinusoidal endothelial cell; macrophage migration inhibitory factor; chemotaxis; metastasis

资金

  1. National Basic Research Program of China (973 program) [2015CB554002, 2010CB529403]
  2. National Natural Science Foundation of China - NSFC-Guangdong Joint Fund [U1201226]
  3. National Natural Science Foundation of China [81090422, 81172381, 81372584, 81472313, 81071735]
  4. Guangdong Provincial Natural Science Foundation of China [S2012010009643]
  5. Science and Technology Innovation Foundation of Guangdong Higher Education [CXZD1016]
  6. National Natural Science Foundation of Guangdong [2010B031500012]
  7. Guangzhou Science & Technology Plan Project [201300000056]

向作者/读者索取更多资源

Growth and invasion of metastatic colorectal cancer (CRC) cells in the liver depend on microenvironment. Here, we showed that human hepatic sinusoidal endothelial cells (HHSECs) induce chemotaxis and outgrowth of CRC cells. Macrophage migration inhibitory factor (MIF), released by HHSECs, stimulated chemotaxis of CRC cells. MIF secreted by HHSECs, but not by CRC cells themselves, promoted migration and epithelial-mesenchymal transition (EMT) and facilitated proliferation and apoptotic resistance of CRC cells. In orthotopic implantation models in nude mice, exogenous MIF stimulated growth of CRC cells and metastasis. Furthermore, MIF accelerated mobility of CRC cells by suppressing F-actin depolymerization and phosphorylating cofilin. Noteworthy, MIF levels were correlated with the size of hepatic metastases. We suggest that HHSECs and paracrine MIF promote initial migration and proliferation of CRC cells in the hepatic sinusoids to generate liver metastases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Distinct contributions of cathelin-related antimicrobial peptide (CRAMP) derived from epithelial cells and macrophages to colon mucosal homeostasis

Keqiang Chen, Teizo Yoshimura, Xiaohong Yao, Wanghua Gong, Jiaqiang Huang, Amiran K. Dzutsev, John McCulloch, Colm O'hUigin, Xiu-wu Bian, Giorgio Trinchieri, Ji Ming Wang

Summary: CRAMP plays a protective role in the mouse colon against inflammation, inflammation-associated carcinogenesis, and disrupted microbiome balance. Epithelial cell-derived CRAMP is crucial for normal development and repair of colon crypts, while myeloid cell-derived CRAMP enhances colon epithelial resistance to bacterial invasion during acute inflammation.

JOURNAL OF PATHOLOGY (2021)

Article Biochemistry & Molecular Biology

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas

Xianwen Ren, Wen Wen, Xiaoying Fan, Wenhong Hou, Bin Su, Pengfei Cai, Jiesheng Li, Yang Liu, Fei Tang, Fan Zhang, Yu Yang, Jiangping He, Wenji Ma, Jingjing He, Pingping Wang, Qiqi Cao, Fangjin Chen, Yuqing Chen, Xuelian Cheng, Guohong Deng, Xilong Deng, Wenyu Ding, Yingmei Feng, Rui Gan, Chuang Guo, Weiqiang Guo, Shuai He, Chen Jiang, Juanran Liang, Yi-min Li, Jun Lin, Yun Ling, Haofei Liu, Jianwei Liu, Nianping Liu, Shu-Qiang Liu, Meng Luo, Qiang Ma, Qibing Song, Wujianan Sun, GaoXiang Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xiaowei Xie, Xinxin Xiong, Xudong Xing, Hao Xu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jin Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Jianfeng Zhou, Wei Zhou, Sujuan Zhong, Xiaosong Zhong, Shuye Zhang, Lin Zhu, Ping Zhu, Bin Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Jin-Xin Bei, Lai Wei, Xiu-Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Fu-Sheng Wang, Hongyang Wang, Bing Su, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang

Summary: The study revealed the presence of immune response dysfunction in COVID-19 patients, with different peripheral immune subtype changes associated with clinical features such as age, sex, severity, and disease stages. Additionally, dramatic transcriptomic changes were observed within virus-infected cells, and upregulation of S100A8/A9 in peripheral blood may contribute to the cytokine storms frequently observed in severe patients.
Article Biochemistry & Molecular Biology

SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination

Zhengrong Zhang, You Zheng, Zubiao Niu, Bo Zhang, Chenxi Wang, Xiaohong Yao, Haoran Peng, Del Nonno Franca, Yunyun Wang, Yichao Zhu, Yan Su, Meng Tang, Xiaoyi Jiang, He Ren, Meifang He, Yuqi Wang, Lihua Gao, Ping Zhao, Hanping Shi, Zhaolie Chen, Xiaoning Wang, Mauro Piacentini, Xiuwu Bian, Gerry Melino, Liang Liu, Hongyan Huang, Qiang Sun

Summary: In COVID-19 patients, SARS-CoV-2 infection leads to the presence of heterotypic cell-in-cell structures in lung tissues with lymphocytes inside multinucleate syncytia. The membrane fusion induced by the spike glycoprotein is controlled by a bi-arginine motif, and candidate anti-viral drugs can efficiently inhibit this process. This study provides insights into the molecular and cellular mechanisms of SARS-CoV-2 pathogenesis and identifies potential novel targets for COVID-19 therapy.

CELL DEATH AND DIFFERENTIATION (2021)

Editorial Material Immunology

Pyroptotic macrophages stimulate the SARS-CoV-2-associated cytokine storm

Jinghe Zhang, Haibo Wu, XiaoHong Yao, Dingyu Zhang, Yonggang Zhou, Binqing Fu, Wei Wang, Heng Li, Zhe Wang, Ziming Hu, Yong Ren, Rui Sun, Zhigang Tian, Xiuwu Bian, Haiming Wei

CELLULAR & MOLECULAR IMMUNOLOGY (2021)

Article Oncology

Combination of p38 MAPK inhibitor with PD-L1 antibody effectively prolongs survivals of temozolomide-resistant glioma-bearing mice via reduction of infiltrating glioma-associated macrophages and PD-L1 expression on resident glioma-associated microglia

Weiqi Dang, Jingfang Xiao, Qinghua Ma, Jingya Miao, Mianfu Cao, Lu Chen, Yu Shi, Xiaohong Yao, Shichang Yu, Xindong Liu, Youhong Cui, Xia Zhang, Xiuwu Bian

Summary: The study demonstrates that a p38MAPK inhibitor can reduce macrophages/microglia accumulation in glioma and prolong the survivals of glioma-bearing mice, potentially through inhibiting PD-L1 expression. The combination therapy of p38MAPK inhibitor with PD-L1 antibody effectively prolongs the survivals of TMZ-resistant GBM-bearing hosts and modulates the immune microenvironment within the tumor. Further clinical studies are needed to confirm the safety and efficacy of this combination therapy.

BRAIN TUMOR PATHOLOGY (2021)

Correction Biochemistry & Molecular Biology

COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas (vol 184, pg 1895, 2021)

Xianwen Ren, Wen Wen, Xiaoying Fan, Wenhong Hou, Bin Su, Pengfei Cai, Jiesheng Li, Yang Liu, Fei Tang, Fan Zhang, Yu Yang, Jiangping He, Wenji Ma, Jingjing He, Pingping Wang, Qiqi Cao, Fangjin Chen, Yuqing Chen, Xuelian Cheng, Guohong Deng, Xilong Deng, Wenyu Ding, Yingmei Feng, Rui Gan, Chuang Guo, Weiqiang Guo, Shuai He, Chen Jiang, Juanran Liang, Yi-min Li, Jun Lin, Yun Ling, Haofei Liu, Jianwei Liu, Nianping Liu, Shu-Qiang Liu, Meng Luo, Qiang Ma, Qibing Song, Wujianan Sun, GaoXiang Wang, Feng Wang, Ying Wang, Xiaofeng Wen, Qian Wu, Gang Xu, Xiaowei Xie, Xinxin Xiong, Xudong Xing, Hao Xu, Chonghai Yin, Dongdong Yu, Kezhuo Yu, Jin Yuan, Biao Zhang, Peipei Zhang, Tong Zhang, Jincun Zhao, Peidong Zhao, Jianfeng Zhou, Wei Zhou, Sujuan Zhong, Xiaosong Zhong, Shuye Zhang, Lin Zhu, Ping Zhu, Bin Zou, Jiahua Zou, Zengtao Zuo, Fan Bai, Xi Huang, Penghui Zhou, Qinghua Jiang, Zhiwei Huang, Jin-Xin Bei, Lai Wei, Xiu-Wu Bian, Xindong Liu, Tao Cheng, Xiangpan Li, Pingsen Zhao, Fu-Sheng Wang, Hongyang Wang, Bing Su, Zheng Zhang, Kun Qu, Xiaoqun Wang, Jiekai Chen, Ronghua Jin, Zemin Zhang

Article Medicine, Research & Experimental

Overexpression of carnitine palmitoyltransferase 1A promotes mitochondrial fusion and differentiation of glioblastoma stem cells

Min Luo, Yu-Qi Liu, Hua Zhang, Chun-Hua Luo, Qing Liu, Wen-Ying Wang, Zhi-Cheng He, Cong Chen, Xiao-Ning Zhang, Min Mao, Kai-Di Yang, Chao Wang, Xiao-Qing Chen, Wen-Juan Fu, Qin Niu, Xiu-Wu Bian, Yu Shi, Yi-Fang Ping

Summary: The study demonstrates that CPT1A plays a critical role in regulating mitochondrial dynamics and GSC differentiation in glioblastoma. Overexpression of CPT1A inhibits GSC self-renewal and promotes mitochondrial fusion, while disruption of CPT1A leads to mitochondrial fission and reprogramming of non-stem tumor cells towards GSC features. This suggests that CPT1A could be a potential target for differentiation therapy in GBM.

LABORATORY INVESTIGATION (2022)

Article Cell Biology

A single-cell transcriptomic landscape of the lungs of patients with COVID-19

Si Wang, Xiaohong Yao, Shuai Ma, Yifang Ping, Yanling Fan, Shuhui Sun, Zhicheng He, Yu Shi, Liang Sun, Shiqi Xiao, Moshi Song, Jun Cai, Jiaming Li, Rui Tang, Liyun Zhao, Chaofu Wang, Qiaoran Wang, Lei Zhao, Huifang Hu, Xindong Liu, Guoqiang Sun, Lu Chen, Guoqing Pan, Huaiyong Chen, Qingrui Li, Peipei Zhang, Yuanyuan Xu, Huyi Feng, Guo-Guang Zhao, Tianzi Wen, Yungui Yang, Xuequan Huang, Wei Li, Zhenhua Liu, Hongmei Wang, Haibo Wu, Baoyang Hu, Yong Ren, Qi Zhou, Jing Qu, Weiqi Zhang, Guang-Hui Liu, Xiu-Wu Bian

Summary: This study provides insights into the molecular basis of lung pathology in COVID-19 patients through multi-omics and single-nucleus transcriptomic analysis, identifying pathological features associated with SARS-CoV-2 infection such as hyperinflammation, alveolar epithelial cell exhaustion, vascular changes, and fibrosis. It also highlights lung senescence as a molecular state of COVID-19 pathology and suggests FOXO3A suppression as a potential mechanism for COVID-19 pulmonary fibrosis.

NATURE CELL BIOLOGY (2021)

Article Cell Biology

Single-cell transcriptomics reveal the heterogeneity and dynamic of cancer stem-like cells during breast tumor progression

Guojuan Jiang, Juchuanli Tu, Lei Zhou, Mengxue Dong, Jue Fan, Zhaoxia Chang, Lixing Zhang, Xiuwu Bian, Suling Liu

Summary: The study constructed a single-cell atlas of tumor progression stages in a breast cancer mouse model, revealing the role of ERlow epithelial cell lineage in tumor initiation and the blockade of differentiation in ERhigh epithelial cell lineage. Furthermore, a stem-like cell cluster was identified within ERlow epithelial cells, showing heterogeneity. This study also highlighted the dynamics of immune cell infiltration and the potential cross-talk between BCSCs and immune cells during breast tumor progression.

CELL DEATH & DISEASE (2021)

Correction Genetics & Heredity

Systemic Delivery of MicroRNA101 Potently Inhibits Hepatocellular Carcinoma In Vivo by Repressing Multiple Targets (vol 11, e1004873, 2015)

Fang Zheng, Yi-Ji Liao, Mu-Yan Cai, Tian-Hao Liu, Shu-Peng Chen, Pei-Hong Wu, Long Wu, Xiu-Wu Bian, Xin-Yuan Guan, Yi-Xin Zeng, Yun-Fei Yuan, Hsiang-Fu Kung, Dan Xie

PLOS GENETICS (2021)

Article Oncology

Identification of a unique tumor cell subset employing myeloid transcriptional circuits to create an immunomodulatory microenvironment in glioblastoma

Kaidi Yang, Yu Shi, Min Luo, Min Mao, Xiaoning Zhang, Cong Chen, Yuqi Liu, Zhicheng He, Qing Liu, Wenying Wang, Chunhua Luo, Wen Yin, Chao Wang, Qin Niu, Hui Zeng, Xiu-Wu Bian, Yi-Fang Ping

Summary: This study used single-cell RNA sequencing and bulk RNA sequencing data to reveal the immune evasion mechanisms of GBM cells and their interactions with immune cells. A new subset of GBM cells, TC-6, was identified with immune-invading characteristics and synergy with tumor-associated macrophages to create an immune-suppressive environment. Three immune subtypes were also identified, with C3 GBMs being enriched with TC-6 cells and immunosuppressive macrophages, which were associated with reduced efficacy of anti-PD-1 treatment. The findings provide new insights into optimizing anti-GBM immunotherapy.

ONCOIMMUNOLOGY (2022)

Article Materials Science, Multidisciplinary

Antisense oligonucleotides-Laden UiO-66@Au nanohybrid for enhanced radiotherapy against hypoxic tumor by dual-inhibition of carbonic anhydrase IX

Kai Wang, Shuaishuai Ding, Lijuan Zeng, Jingrong Zhou, Yuhua Cao, Jiaqian Wu, Lu Lu, Xiu-wu Bian, Gan Tian

Summary: A dual exogenous/endogenous CA IX inhibition strategy using metal-organic framework/gold nanoparticles nanohybrids was developed for hypoxia-relief enhanced radiation therapy of triple negative breast cancer. This strategy effectively alleviated hypoxia-induced resistance by combining external and internal inhibition methods, along with radiotherapy, to achieve a synergistic therapeutic outcome.

APPLIED MATERIALS TODAY (2021)

Article Cell Biology

KPT330 promotes the sensitivity of glioblastoma to olaparib by retaining SQSTM1 in the nucleus and disrupting lysosomal function

Li-Hong Wang, Sen Wei, Ye Yuan, Ming-Jun Zhong, Jiao Wang, Ze-Xuan Yan, Kai Zhou, Tao Luo, Li Liang, Xiu-Wu Bian

Summary: PARP inhibitors have limited efficacy when used alone in glioblastoma (GBM) patients, leading researchers to explore combination therapies. This study found that concurrent treatment with the PARP inhibitor olaparib and XPO1 inhibitor KPT330 showed synergistic anticancer effects on GBM cells. Mechanistically, KPT330 induced the nuclear retention of SQSTM1 and inhibited the ubiquitination of the DNA repair signal H2AX mediated by olaparib in the nucleus, inhibiting DNA damage response and repair in GBM. In the cytoplasm, KPT330 blocked autophagic flux and induced dysfunction of lysosomes, ultimately promoting cell death.

AUTOPHAGY (2023)

Article Oncology

Combination of genomic instability score and TP53 status for prognosis prediction in lung adenocarcinoma

Juan Feng, Yang Lan, Feng Liu, Ye Yuan, Jia Ge, Sen Wei, Hu Luo, Jianjun Li, Tao Luo, Xiuwu Bian

Summary: The genomic instability/homologous recombination deficiency (GI/HRD) score has prognostic value in lung adenocarcinoma, particularly when combined with TP53 status, but is not applicable for all types of lung cancer.

NPJ PRECISION ONCOLOGY (2023)

Article Biochemistry & Molecular Biology

EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma

Qu-Jing Gai, Zhen Fu, Jiang He, Min Mao, Xiao-Xue Yao, Yan Qin, Xi Lan, Lin Zhang, Jing-Ya Miao, Yan-Xia Wang, Jiang Zhu, Fei-Cheng Yang, Hui-Min Lu, Ze-Xuan Yan, Fang-Lin Chen, Yu Shi, Yi-Fang Ping, You-Hong Cui, Xia Zhang, Xindong Liu, Xiao-Hong Yao, Sheng-Qing Lv, Xiu-Wu Bian, Yan Wang

Summary: PDGFRA may not be necessary for PDGFA function. The study revealed EPHA2 as a potential receptor of PDGFA and identified that co-upregulation of PDGFA and EPHA2 led to worse patient prognosis and poorer therapeutic effects. Combination inhibitors targeting PDGFRA and EHA2 represent a promising therapeutic strategy for GBM treatment.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

暂无数据